Skip to main content

Table 3 Survival data

From: Prostate-specific membrane antigen (PSMA) expression in adenoid cystic carcinoma of the head and neck

 

N affected

Median months

% survival

Overall survival

   5-year OS

25

36

77%

   10-year OS

29

41

74%

Disease-specific survival

   5-year DSS

17

41

85%

   10-year DSS

21

47

81%

Disease-free survival

   5-year DFS

36

20

67%

   10-year DFS

49

31

55%

Locoregional recurrence-free survival

   5-year RFS

19

27

83%

   10-year RFS

26

36

76%

Metastatic-free survival

   5-year MFS

26

22

76%

   10-year MFS

33

28

70%